A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

被引：0
|
作者：
Kei Hosoda
Mizutomo Azuma
Chikatoshi Katada
Kenji Ishido
Masahiro Niihara
Hideki Ushiku
Mikiko Sakuraya
Marie Washio
Takuya Wada
Akinori Watanabe
Hiroki Harada
Satoshi Tanabe
Wasaburo Koizumi
Keishi Yamashita
Naoki Hiki
机构：
[1] Kitasato University School of Medicine,Department of Upper Gastrointestinal Surgery
[2] Kitasato University School of Medicine,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Locally advanced esophagogastric junction cancer; Docetaxel; Oxaliplatin; S-1; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1097
页数：7
相关论文
共 50 条
  • [41] Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
    Mitsuhiko Ota
    Hiroshi Saeki
    Hideo Uehara
    Yoshiko Matsuda
    Satoshi Tsutsumi
    Tetsuya Kusumoto
    Hisateru Yasui
    Yasunari Ubukata
    Shohei Yamaguchi
    Hiroyuki Orita
    Naoki Izawa
    Saburo Kakizoe
    Mototsugu Shimokawa
    Tomoharu Yoshizumi
    Yoshihiro Kakeji
    Masaki Mori
    Eiji Oki
    International Journal of Clinical Oncology, 2023, 28 : 1166 - 1175
  • [42] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Takayama, T.
    Sato, Y.
    Sagawa, T.
    Okamoto, T.
    Nagashima, H.
    Takahashi, Y.
    Ohnuma, H.
    Kuroiwa, G.
    Miyanishi, K.
    Takimoto, R.
    Matsunaga, T.
    Kato, J.
    Yamaguchi, K.
    Hirata, K.
    Niitsu, Y.
    BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 851 - 856
  • [43] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [44] Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer
    Ozaki, Tomohiro
    Tamura, Kenji
    Satoh, Taroh
    Kurata, Takayasu
    Shimizu, Toshio
    Miyazaki, Masaki
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    Fukuoka, Masahiro
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2657 - 2665
  • [45] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Yoshitaka Honma
    Yasuhide Yamada
    Tetsuji Terazawa
    Atsuo Takashima
    Satoru Iwasa
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhiro Shimada
    Masaki Ohashi
    Shinji Morita
    Takeo Fukagawa
    Nozomu Machida
    Hitoshi Katai
    Surgery Today, 2016, 46 : 1076 - 1082
  • [46] Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer
    Dae Young Zang
    Dae Hyun Yang
    Min-Jeong Kim
    Kyung Mi Jang
    Se Won Hwang
    Kyo-Sang Yoo
    Taeho Han
    Ho Young Kim
    Hyo Jung Kim
    Jung Hye Kwon
    Hun Ho Song
    Sarah Park
    Joo Young Jung
    Hyeong Su Kim
    Jung Han Kim
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 877 - 883
  • [47] Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer
    Zang, Dae Young
    Yang, Dae Hyun
    Kim, Min-Jeong
    Jang, Kyung Mi
    Hwang, Se Won
    Yoo, Kyo-Sang
    Han, Taeho
    Kim, Ho Young
    Kim, Hyo Jung
    Kwon, Jung Hye
    Song, Hun Ho
    Park, Sarah
    Jung, Joo Young
    Kim, Hyeong Su
    Kim, Jung Han
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 877 - 883
  • [48] Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
    Ozdemir, Nuriye
    Abali, Huseyin
    Vural, Murat
    Yalcin, Suayib
    Oksuzoglu, Berna
    Civelek, Burak
    Oguz, Dilek
    Bostanci, Birol
    Yalcin, Bulent
    Zengin, Nurullah
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1139 - 1147
  • [49] Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease:: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001
    Hejna, Michael
    Raderer, Markus
    Zacherl, Johannes
    Ba-Ssalamah, Ahmed
    Puespoek, Andreas
    Schmidinger, Manuela
    Pluschnig, Ursula
    Brodowicz, Thomas
    Zielinski, Christoph C.
    ANTI-CANCER DRUGS, 2008, 19 (05) : 535 - 539
  • [50] Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
    Liu, Yan
    Feng, Ye
    Gao, Yongjian
    Hou, Ruizhi
    ONCOTARGETS AND THERAPY, 2016, 9 : 1269 - 1273
12345